These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33870245)

  • 1. Cross sectional investigation of a COVID-19 outbreak at a London Army barracks: Neutralising antibodies and virus isolation.
    Taylor H; Wall W; Ross D; Janarthanan R; Wang L; Aiano F; Ellis J; Gopal R; Andrews N; Patel M; Lackenby A; Myers R; Ramsay ME; Chow JY; Zambon M; Ladhani SN
    Lancet Reg Health Eur; 2021 Mar; 2():100015. PubMed ID: 33870245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.
    He Z; Ren L; Yang J; Guo L; Feng L; Ma C; Wang X; Leng Z; Tong X; Zhou W; Wang G; Zhang T; Guo Y; Wu C; Wang Q; Liu M; Wang C; Jia M; Hu X; Wang Y; Zhang X; Hu R; Zhong J; Yang J; Dai J; Chen L; Zhou X; Wang J; Yang W; Wang C
    Lancet; 2021 Mar; 397(10279):1075-1084. PubMed ID: 33743869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19: Prospective cohort study, England.
    Ladhani SN; Jeffery-Smith A; Patel M; Janarthanan R; Fok J; Crawley-Boevey E; Vusirikala A; Fernandez Ruiz De Olano E; Perez MS; Tang S; Dun-Campbell K; Evans EW; Bell A; Patel B; Amin-Chowdhury Z; Aiano F; Paranthaman K; Ma T; Saavedra-Campos M; Ellis J; Chand M; Brown K; Ramsay ME; Hopkins S; Shetty N; Chow JY; Gopal R; Zambon M
    EClinicalMedicine; 2020 Nov; 28():100597. PubMed ID: 33173854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
    Khan M; Khan H; Khan S; Nawaz M
    J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
    [No Abstract]   [Full Text] [Related]  

  • 8. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
    Kreuzberger N; Hirsch C; Chai KL; Tomlinson E; Khosravi Z; Popp M; Neidhardt M; Piechotta V; Salomon S; Valk SJ; Monsef I; Schmaderer C; Wood EM; So-Osman C; Roberts DJ; McQuilten Z; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013825. PubMed ID: 34473343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study.
    Guo L; Wang G; Wang Y; Zhang Q; Ren L; Gu X; Huang T; Zhong J; Wang Y; Wang X; Huang L; Xu L; Wang C; Chen L; Xiao X; Peng Y; Knight JC; Dong T; Cao B; Wang J
    Lancet Microbe; 2022 May; 3(5):e348-e356. PubMed ID: 35345417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021.
    Cohen C; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; du Plessis M; Carrim M; Buys A; Martinson NA; Kahn K; Tollman S; Lebina L; Wafawanaka F; du Toit J; Xavier Gómez-Olivé F; Dawood FS; Mkhencele T; Sun K; Viboud C; ; Tempia S
    medRxiv; 2021 Dec; ():. PubMed ID: 34909794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic].
    Erensoy S
    Mikrobiyol Bul; 2020 Jul; 54(3):497-509. PubMed ID: 32755524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort study.
    Regev-Yochay G; Lustig Y; Joseph G; Gilboa M; Barda N; Gens I; Indenbaum V; Halpern O; Katz-Likvornik S; Levin T; Kanaaneh Y; Asraf K; Amit S; Rubin C; Ziv A; Koren R; Mandelboim M; Tokayer NH; Meltzer L; Doolman R; Mendelson E; Alroy-Preis S; Kreiss Y
    Lancet Microbe; 2023 May; 4(5):e309-e318. PubMed ID: 36963419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 lateral flow IgG seropositivity and serum neutralising antibody responses after primary and booster vaccinations in Chile: a cross-sectional study.
    Sauré D; O'Ryan M; Torres JP; Zuñiga M; Soto-Rifo R; Valiente-Echeverría F; Gaete-Argel A; Neira I; Saavedra V; Acevedo ML; Archila C; Acuña F; Rain M; Basso LJ
    Lancet Microbe; 2023 Mar; 4(3):e149-e158. PubMed ID: 36716754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study.
    Schlottau K; Rissmann M; Graaf A; Schön J; Sehl J; Wylezich C; Höper D; Mettenleiter TC; Balkema-Buschmann A; Harder T; Grund C; Hoffmann D; Breithaupt A; Beer M
    Lancet Microbe; 2020 Sep; 1(5):e218-e225. PubMed ID: 32838346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers.
    Murata T; Sakurai A; Suzuki M; Komoto S; Ide T; Ishihara T; Doi Y
    mSphere; 2021 May; 6(3):. PubMed ID: 34011679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into the practical performance of RT-PCR testing for SARS-CoV-2 using serological data: a cohort study.
    Zhang Z; Bi Q; Fang S; Wei L; Wang X; He J; Wu Y; Liu X; Gao W; Zhang R; Gong W; Su Q; Azman AS; Lessler J; Zou X
    Lancet Microbe; 2021 Feb; 2(2):e79-e87. PubMed ID: 33495759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study.
    Chia WN; Zhu F; Ong SWX; Young BE; Fong SW; Le Bert N; Tan CW; Tiu C; Zhang J; Tan SY; Pada S; Chan YH; Tham CYL; Kunasegaran K; Chen MI; Low JGH; Leo YS; Renia L; Bertoletti A; Ng LFP; Lye DC; Wang LF
    Lancet Microbe; 2021 Jun; 2(6):e240-e249. PubMed ID: 33778792
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.